Literature DB >> 9419173

Complement activation in patients with sepsis is in part mediated by C-reactive protein.

G J Wolbink1, A W Bossink, A B Groeneveld, M C de Groot, L G Thijs, C E Hack.   

Abstract

The involvement of C-reactive protein (CRP) in the activation of complement in patients with sepsis was investigated. In 104 patients with infections of varying severity, circulating levels of CRP-complement complexes, which are specific indicators for CRP-mediated complement activation, were assessed. Complement-CRP complexes were increased in almost all patients and correlated significantly with levels of C3a (r = .59; P < .001) and C-reactive protein (r = .76; P < .001). In addition, they correlated with levels of secretory phospholipase A2 (r = .59; P < .001). Levels of complement-CRP complexes in patients with a pneumococcal type of infection were similar to those in patients with other types of infections. Complement-CRP complexes were significantly higher in patients with shock (P = .01) and in patients who died (P = .03). These results demonstrate that part of the complement activation in patients with sepsis is independent from a direct interaction with microorganisms but rather results from an endogenous mechanism involving CRP.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9419173     DOI: 10.1086/513803

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

1.  Circulating inflammatory mediators in patients with fever: predicting bloodstream infection.

Authors:  A B Groeneveld; A W Bossink; G J van Mierlo; C E Hack
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

2.  Sustained activation of neutrophils in the course of Kawasaki disease: an association with matrix metalloproteinases.

Authors:  M H Biezeveld; G van Mierlo; R Lutter; I M Kuipers; T Dekker; C E Hack; J W Newburger; T W Kuijpers
Journal:  Clin Exp Immunol       Date:  2005-07       Impact factor: 4.330

Review 3.  Complement and autoimmunity.

Authors:  Eleonora Ballanti; Carlo Perricone; Elisabetta Greco; Marta Ballanti; Gioia Di Muzio; Maria Sole Chimenti; Roberto Perricone
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829

4.  Analytical performance of a highly sensitive C-reactive protein-based immunoassay and the effects of laboratory variables on levels of protein in blood.

Authors:  Najib Aziz; John L Fahey; Roger Detels; Anthony W Butch
Journal:  Clin Diagn Lab Immunol       Date:  2003-07

5.  Circulating concentrations of soluble granzyme A and B increase during natural and experimental Plasmodium falciparum infections.

Authors:  C C Hermsen; Y Konijnenberg; L Mulder; C Loé; M van Deuren; J W M van der Meer; G J van Mierlo; W M C Eling; C E Hack; R W Sauerwein
Journal:  Clin Exp Immunol       Date:  2003-06       Impact factor: 4.330

6.  Rat C-reactive protein activates the autologous complement system.

Authors:  Niubel Diaz Padilla; Wim K Bleeker; Yvonne Lubbers; Gemma M M Rigter; Gerard J Van Mierlo; Mohamed R Daha; C Erik Hack
Journal:  Immunology       Date:  2003-08       Impact factor: 7.397

7.  C-reactive protein activates complement in infarcted human myocardium.

Authors:  Remco Nijmeijer; Wim K Lagrand; Yvonne T P Lubbers; Cees A Visser; Chris J L M Meijer; Hans W M Niessen; C Erik Hack
Journal:  Am J Pathol       Date:  2003-07       Impact factor: 4.307

8.  Cardiovascular disease could be contained based on currently available data!

Authors:  Okom Nkili F C Ofodile
Journal:  Dose Response       Date:  2006-09-23       Impact factor: 2.658

Review 9.  Bench-to-bedside review: functional relationships between coagulation and the innate immune response and their respective roles in the pathogenesis of sepsis.

Authors:  Steven M Opal; Charles T Esmon
Journal:  Crit Care       Date:  2002-12-20       Impact factor: 9.097

10.  Complement depletion deteriorates clinical outcomes of severe abdominal sepsis: a conspirator of infection and coagulopathy in crime?

Authors:  Jianan Ren; Yunzhao Zhao; Yujie Yuan; Gang Han; Weiqin Li; Qian Huang; Zhihui Tong; Jieshou Li
Journal:  PLoS One       Date:  2012-10-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.